BDBM260565 US10300066, Compound 39::US9532990, 39

SMILES Nc1ncnc2c1c(-c1ccc(Oc3c(F)c(F)cc(F)c3F)cc1F)nn2C1CCC(NC(=O)CSSCC(=O)NC2CCC(n3nc(-c4ccc(Oc5c(F)c(F)cc(F)c5F)cc4F)c4c(N)ncnc43)CC2)CC1

InChI Key InChIKey=PJHYAJLGIPWHHQ-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 260565   

TargetTyrosine-protein kinase BTK(Human)
Zhejiang Dtrm Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 260565BDBM260565(US9532990, 39 | US10300066, Compound 39)
Affinity DataIC50: 22nMT: 2°CAssay Description:The enzyme reaction mixture of BTK wild type standard HTRF assay contained 1 nM BTK wild type, 1 μM biotin-TK1 peptide, and 30 μM ATP in a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2017
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Zhejiang Dtrm Biopharma

US Patent
LigandChemical structure of BindingDB Monomer ID 260565BDBM260565(US9532990, 39 | US10300066, Compound 39)
Affinity DataIC50: 22nMAssay Description:The enzyme reaction mixture of BTK wild type standard HTRF assay contained 1 nM BTK wild type, 1 μM biotin-TK1 peptide, and 30 μM ATP in a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2020
Entry Details
US Patent